BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

osiris.com Pages on BioPortfolio:

BioPortfolio - Osiris Therapeutics
Osiris Therapeutics - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/7942-Osiris_Therape...

Biotechnology News stem cells carticel. chondrogen. prochym. gvhd ...
United States: Genzyme and Osiris collaborate to develop adult stem cell products ... Genzyme and Osiris Partner to Develop and Commercialize First-in-
Class ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Osiris Therapeutics - Profile
View the current Osiris Therapeutics Page on BioPortfolio.com ... Leading the way to a better tomorrow Osiris Therapeutics, Inc. is a company founded to ...
http://www.bioportfolio.com/biocorporate/7942-Osiris%252BThe...

Biotechnology News Genzyme Search
Genzyme and Osiris Forge Stem-Cell Agreement, Xtalic Nabs $10M for Nano Alloys, ... United States: Genzyme and Osiris collaborate to develop adult stem cell ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - www.osiris.com
www.osiris.com - BioPortfolio. ... Osiris.com. The presentation will be archived on the Osiris website for a . ...
http://www.bioportfolio.com/search/www.osiris.com.html...

Biotechnology News regulatory chondrogen. prochym. carticel. osiri ...
BioWatch: Osiris deal could reap $1.3 billion ... Osiris Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - osiris therapeutics was founded in
Leading the way to a better tomorrow Osiris Therapeutics, Inc. is a company founded to ... Nexell Therapeutics Novocell Organogenesis Osiris Therapeutics .
...
http://www.bioportfolio.com/search/osiris_therapeutics_was_f...

Biotechnology News stem cell greko. rsci. dubai. dcaaam. cong ...
Osiris Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - mscs cardiac osiris patent
mscs cardiac osiris patent - BioPortfolio. ... Osiris Therapeutics - Entry on Bioportfolio's Biocorporate Database. ... osiris therapeutics | mscs cardiac ...
http://www.bioportfolio.com/search/mscs_cardiac_osiris_paten...

Biotechnology News Paresthesia fabrazym. fabri. gl. 1mgkg. genzym ...
Genzyme Corp and Osiris Therapeutics have entered a strategic alliance for the ... Zacks Bull and Bear of the Day Highlights: Osiris Pharmaceuticals, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Results from other life science and pharmaceutical sites:

Stem Cell Therapy - Adult Stem Cell Treatment and Research
Adult stem cell therapy from Osiris brings regenerative medicine with the first products to assist in stem cell treatment including bone marrow transplant ...
http://www.osiristx.com/...

BioPortfolio - Osiris Therapeutics
Osiris Therapeutics - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/7942-Osiris_Therape...

Crohn's Disease – Crohn's Disease Mesenchymal Stem Cell Treatment ...
2008 Osiris Therapeutics, Inc. 7015 Albert Einstein Drive · Columbia, MD · 21046 · p(443)545-1800 · f(443)545-1701 osiris@osiris.com ...
http://www.osiristx.com/clinical_trials_prochymal_crohns.php...

Osiris Announces Third Quarter 2008 Financial Results Conference ...
Osiris Announces Third Quarter 2008 Financial Results Conference Call. - COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR - News),
...
http://biz.yahoo.com/bw/081031/20081031005963.html?.v=1...

Osiris Therapeutics Reports Third Quarter 2008 Financial Results
Osiris reported net income of $5.3 million for the third quarter of 2008 compared ... Osiris Therapeutics, Inc. is a leading stem cell therapeutic
company ...
http://www.osiristx.com/pdf/PR%2097%2004Nov08%203Q%202008%20...

Osiris Therapeutics, Inc. Receives Approval for Use of Prochymal ...
In support of the expanded access treatment program, Osiris submitted summary safety and efficacy data to FDA. Prochymal was evaluated in pediatric patients
...
http://www.biospace.com/news_story.aspx?NewsEntityId=95506...

Osiris Therapeutics to Present at the Rodman & Renshaw 10 Annual ...
Osiris Therapeutics, Inc. is a leading stem cell therapeutic company ... trademarks of Osiris Therapeutics, Inc. More information can be found on the ...
http://www.osiristx.com/pdf/PR%2098%2006Nov08%20Osiris%20Pre...

Osiris Therapeutics Reports Third Quarter 2008 Financial Results ...
4 Nov 2008 ... Osiris Therapeutics Reports Third Quarter 2008 Financial Results. - COLUMBIA, Md .--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR ...
http://biz.yahoo.com/bw/081104/20081104005553.html?.v=1...

Scientist, Discovery Job, Osiris Therapeutics, Inc., Columbia ...
5 Apr 2008 ... Primary Purpose of this Position: The Research Scientist (Discovery) position will directly participate in the identification and evaluation ...
http://www.biospace.com/job_view.aspx?JOB_ID=234847...

News: Osiris Therapeutics Reports Third Quarter 2008 Financial ...
Osiris Therapeutics Reports Third Quarter 2008 Financial Results. Genetic Engineering & Biotechnology News - Biotechnology from Bench to Business.
http://www.genengnews.com/news/bnitem.aspx?name=44803799&tax...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.